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FluorometholoneAbstract The determination of sodium cromoglicate (SCG) and ﬂuorometholone (FLU) in oph-
thalmic solution was developed by simple, sensitive and precise methods. Three spectrophotometric
methods were applied: absorptivity factor (a-Factor method), absorption factor (AFM) and mean
centering of ratio spectra (MCR). The linearity ranges of SCG were found to be (2.5–35 lg/mL) for
(a-Factor method) and (MCR); while for (AFM), it was found to be (7.5–50 lg/mL). The linearity
ranges of FLU were found to be (4–16 lg/mL) for (a-Factor method) and (AFM); while for
(MCR), it was found to be (2–16 lg/mL). The mean percentage recoveries/RSD for SCG were
found to be 100.31/0.90, 100.23/0.57 and 100.43/1.21; while for FLU, they were found to be
100.11/0.56, 99.97/0.35 and 99.94/0.88 using (a-Factor method), (AFM) and (MCR), respectively.
A TLC-spectrodensitometric method was developed by separation of SCG and FLU on silica gel 60
F254 using chloroform:methanol:toluene:triethylamine in the ratio of (5:2:4:1 v/v/v/v) as developing
system, followed by spectrodensitometric measurement of the bands at 241 nm. The linearity ranges
and the mean percentage recoveries/RSD were found to be (0.4–4.4 lg/band), 100.24/1.44 and (0.2–
1.6 lg/band), 99.95/1.50 for SCG and FLU, respectively. A comparative study was conducted
between the proposed methods to discuss the advantage of each method. The suggested methods
were validated in compliance with the ICH guidelines and were successfully applied for the deter-
Figure 1 The chem
412 S.S. Saleh et al.mination of SCG and FLU in their laboratory prepared mixtures and commercial ophthalmic
solution in the presence of benzalkonium chloride as a preservative. These methods could be an
alternative to different HPLC techniques in quality control laboratories lacking the required facil-
ities for those expensive techniques.
ª 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Sodium cromoglicate (SCG) [disodium 4,40-dioxo-5,50-
(2-hydroxytrimethylenedioxy)di(4H-chromene-2-carboxylate)]
is a mast cell stabilizer that inhibits the release of histamine
and other inﬂammatory mediators from sensitized mast
cells. Fluorometholone (FLU) [9a-ﬂuoro-11b,17a-dihydroxy-
6a-methylpregna-1,4-diene-3,20-dione] is a corticosteroid
employed for its glucocorticoid activity. Both drugs are
formulated together in the form of ophthalmic solution for
treatment of allergic conjunctivitis and vernal keratoconjuncti-
vitis (Sweetman, 2005). The chemical structures of both drugs
(British Pharmacopoeia, 2009) were shown in Fig. 1.
A survey of the literature revealed that the methods re-
ported for the determination of SCG are UV spectrophotom-
etry (Hassib et al., 2011; Tillman and Whymark, 1971), HPLC
(Ali et al., 2008; Ozoux et al., 2001), TLC (Kocic´-Pesic´ et al.,
1992) and capillary electrophoresis (Helle et al., 2008). The
methods reported for FLU are UV spectrophotometry
(Vladimirov et al., 1996; Altuntas et al., 2000) and HPLC
(Korpi-Steiner et al., 2010; Croesa et al., 2009; O’keeffe
et al., 2003). No methods have been reported for the analysis
of the binary mixture of the two drugs. This work aims to pres-
ent simple, accurate and precise spectrophotometric and
TLC- spectrodensitometric methods for the simultaneous
determination of SCG and FLU.
1.1. Theory of the novel absorptivity factor spectrophotometric
method (a-Factor method)
Samir et al. (2012) introduced the novel absorptivity factor
spectrophotometric method. It depends on applying a simple
mathematic equation to calculate the concentration of both
components in a binary mixture where there is a large differ-
ence in the absorptivity between both components in a mix-
ture, so that no isoabsorptive point occurs. In this case
simultaneous determination of each drug in the presence of
the other cannot be carried out by applying the isoabsorptive
point technique.
For a mixture of two drugs X and Y, the concentration of
Y can be determined by using any of the well-established spec-ical structures of (a) sodium cromtrophotometric methods, while X can only be determined
using the absorptivity factor method. This method depends
on the calculation of the absorptivity factor which is the ratio
between the two absorptivities (ax, aY) at an intersection point
with the same absorbance value. This point is called the
absorptivity factor point (kF). This is summarized as follows:
Ax ¼ Ay
axbxCx ¼ aybYCY ðwhere bx ¼ bY ¼ 1cmÞ
axCx ¼ ayCY
ax=ay ¼ Cy=Cx
ax=ay ¼ F
ax ¼ Fay
where, F is the absorptivity factor and ax and aY are the
absorptivities of X and Y respectively.
For a mixture of X and Y the total absorbance of X and Y
at absorptivity factor point kF in UV can be expressed as
follows:
Am ¼ Ax þ Ay
Am ¼ axbxCx þ aybYCY ðwhere bx¼bY ¼ 1cmÞ
Am ¼ axCx þ ayCY
where
AX, Ay and Am are the UV absorbance of X, Y and their
mixture at kF respectively.
Cx and CY are the concentrations of X and Y respectively.
ax and aY are the absorptivities of X and Y at kF
respectively.
ax is substituted by F ay.
Am ¼ aYFCx þ aYCY
Am ¼ aYðFCx þ CYÞoglicate (SCG) and (b) ﬂuorometholone (FLU).
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(FCx + CY) can be calculated by using a regression equation
representing the linear relationship between the absorbance
of Y and its corresponding concentration at the absorptivity
factor point. Thus, if the concentration of Y can be determined
separately by any other method such as direct spectrophotom-
etry, derivative or derivative ratio, then the concentration of X
can be determined after subtraction of concentration Y and
multiplication by the inverse of F or vice versa.
CX ¼ ðFCx þ CYÞ  CY ¼ FCx
Cx ¼ FCxX 1=F
Or
CY ¼ ðFCx þ CYÞ  CxXF2. Experimental
2.1. Apparatus and software
Shimadzu - UV 1800 double beam UV–visible spectrophotom-
eter (Japan) with matched 1 cm quartz cells at 200–800 nm
range was used for all absorbance measurements. Spectra were
automatically obtained by Shimadzu UV-Probe 2.32 system
software. For the mean centering for ratio spectra method,
Matlab Version 7.9 was used.
The TLC- spectrodensitometric system: Camag TLC scan-
ner 3 S/N 130319 operated with winCATS software, Linomat
5 autosampler (Switzerland), Camag microsyringe (100 lL)
and TLC aluminum sheet (20 · 20 cm) precoated with silica
gel 60 F254 (Merck KgaA, Darmstad, Germany) were used.
2.2. Chemicals and reagents
2.2.1. Pure samples
Sodium cromoglycate (SCG) was kindly supplied by Sigma
Pharmaceutical Industries Limited, Al-Monofeya, Egypt.
While ﬂuorometholone (FLU) was kindly supplied by Egypt
Egyptian International Pharmaceutical Industries Co., (EIPI-
CO), Cairo, Egypt. Their purity was found to be
100.80 ± 0.74 and 100.12 ± 0.52 for SCG and FLU respec-
tively by the ofﬁcial methods (British Pharmacopoeia, 2009).
2.2.2. Market sample
Fluca eye drops, labeled to contain 20 mg of SCG and 1 mg
of FLU per 1 mL (batch no. LM036), were manufactured by
Jamjoompharma, Kingdom of Saudi Arabia.
2.2.3. Solvents
Spectroscopic analytical grade of methanol, chloroform, and
triethylamine, supplied from (S.d.ﬁne-chem limited- Mumbai);
analytical grade of Toluene supplied from (Adwic- El Nasr
pharmaceutical Chemicals Co., Egypt) and distilled water were
used.
2.3. Standard solutions
Stock solutions were prepared in a solvent mixture of metha-
nol:water (50:50 v/v), of concentration 1 mg/mL and 0.5 mg/mL,
respectively; and stored in dark bottles at 4 C.Working solutions were freshly prepared by dilution from
the stock solutions with solvent mixture to get 50 lg/mL and
20 lg/mL (for spectrophotometric methods) and 800 and
400 lg/mL (for TLC- spectrodensitometric method) of SCG
and FLU respectively.
2.4. Procedure
2.4.1. For spectrophotometric methods
2.4.1.1. Linearity. 2.4.1.1.1. Linearity of SCG. Aliquots (0.5–
8 mL) of SCG working solution (50 lg/mL) were transferred
into a series of 10 mL volumetric ﬂasks, and the volume was
completed with solvent mixture. The absorption spectra were
measured for the prepared solutions at (200–400 nm). Calibra-
tion curves were constructed relating the D0 absorbance at
227.8 and 325 nm to the corresponding concentration against
solvent mixture as a blank and the regression equation was
computed. The absorption factor for SCG was calculated by
dividing the absorbance at k1 (241 nm)/k2 (325 nm). The ﬁrst
derivative D1 was calculated for the obtained spectra. Calibra-
tion curve was constructed relating the D1 amplitude at
241.5 nm to the corresponding concentration and the regres-
sion equation was computed. The zero order spectra of the
prepared solutions were divided by the spectrum of 8 lg/mL
FLU. The ratio spectra were exported to Matlab to perform
mean centering with respect to wavelength (200–300 nm) to
obtain the mean centered ratio spectra (MC). Calibration
curve was constructed relating the peak amplitude of MC at
252.2 nm to the corresponding concentrations and the regres-
sion equation was computed.
2.4.1.1.2. Linearity of FLU. Aliquots (1.0–8.0 mL) of FLU
working solution (20 lg/mL) were transferred into a series of
10 mL volumetric ﬂasks, and the volume was completed with
solvent mixture. The absorption spectra were measured for
the prepared solutions at (200–400 nm). Calibration curves
were constructed relating the D0 absorbance at 241 and
227.8 nm to the corresponding concentration against solvent
mixture as a blank and the regression equation was computed.
The zero order spectra of the prepared solutions were divided
by the spectrum of 10 lg/mL SCG.
The ratio spectra were exported to Matlab to perform mean
centering with respect to wavelength (200–350 nm) to obtain
the mean centered ratio spectra (MC). Calibration curve was
constructed relating the maximum peak amplitude of MC at
252.2 nm to the corresponding concentrations and the regres-
sion equation was computed.
2.4.1.2. Application to laboratory prepared mixtures. Into two
series of 10 mL volumetric ﬂasks (A and B), accurate aliquots
of SCG and FLU were transferred from their working solu-
tions (50 and 20 lg/mL), respectively, to prepare mixtures con-
taining different ratios of the two drugs. Each ﬂask in the
second series (B) was spiked with 40 lg of FLU from its work-
ing solution (2 mL). Complete both series to volume with the
solvent mixture. Record and store the spectra of the prepared
solutions of both series from 200 to 400 nm. SCG was deter-
mined using series A, FLU was determined using series B. Pro-
ceed as detailed under linearity for both drugs. The
concentration of each drug was calculated using the corre-
sponding regression equation. The claimed concentration of
FLU in each mixture was calculated after subtraction of the
414 S.S. Saleh et al.added concentration (FLU solution 4 lg/mL analyzed by
using the same procedure).
2.4.1.3. Application to pharmaceutical preparation. One millili-
ter was accurately transferred from Fluca eye drops to a
100 mL volumetric ﬂask and diluted to the mark with solvent
mixture to get 200 lg/mL of SCG and 10 lg/mL of FLU; the
prepared solution was ﬁltered through a 0.45 lmMillipore syr-
inge membrane ﬁlter. One milliliter of the prepared solution
was transferred into two separate 10 mL volumetric ﬂasks.
Complete the ﬁrst ﬂask to volume with solvent mixture to ob-
tain solution with a ﬁnal concentration 20 lg/mL of SCG and
1 lg/mL of FLU, while the second ﬂask was spiked with 40 lg
of FLU from its working solution (2 mL) and complete to vol-
ume with solvent mixture. SCG was determined from the ﬁrst
ﬂask and FLU was determined from the second ﬂask. Proceed
as detailed under linearity for both drugs. The concentration
of each drug was calculated using the corresponding regression
equation. The claimed concentration of FLU in the solution
was calculated after subtraction of the added concentration
(FLU solution 4 lg/mL analyzed by using the same proce-
dure). When carrying out the standard addition technique, dif-
ferent known concentrations of pure standard SCG and FLU
were added to the pharmaceutical dosage form before proceed-
ing in the previously mentioned methods.
2.4.2. For TLC-spectrodensitometric method
2.4.2.1. Chromatographic conditions. TLC aluminum sheets
20 · 10 cm precoated with 0.25 mm silica gel 60 F254 were
used. The samples were applied as bands (bandwidth: 6 mm,
bands were spaced 1 cm apart from each other and 1.5 cm
from the bottom edge of the plate). The developing system
was chloroform:methanol:toluene:triethylamine (5:2:4:1 v/v/v/
v). Linear ascending development was done in a chromato-
graphic tank previously saturated with the developing system
for 1 h at room temperature to a distance of approximately
8 cm from the lower edge. The developed plates were air dried
and scanned at 241 nm. The detection was done using Camage
TLC scanner 3 operated in the absorbance mode; with
deuterium lamp as a source of radiation; the slit dimension
was kept at 3 mm · 0.45 mm and 20 mm/s scanning speed
was employed.
2.4.2.2. System suitability. Parameters including resolution
(Rs) and peak symmetry were calculated and compared to ref-
erence value (United States Pharmacopoeia Commission
(2004).
2.4.2.3. Linearity. Aliquot volumes (0.5–5.5 mL) of SCG and
(0.5–4 mL) of FLU were separately transferred from their
working solutions into 10 mL volumetric ﬂasks and diluted
to volume with solvent mixture. Ten microliters of each solu-
tion was applied to a TLC plate using a 100 lL syringe. The
chromatographic conditions were applied and the chromato-
grams were recorded. The calibration curves were plotted be-
tween the recorded peak area · 102 and the corresponding
concentrations, from which the regression equations were cal-
culated. The calibration curves were made from the average of
three experiments.
2.4.2.4. Assay of laboratory-prepared mixtures. Different ali-
quot volumes of both drugs were accurately transferred fromtheir working solutions and mixed to prepare solutions of dif-
ferent ratios. Ten microliters of each solution was applied to a
TLC plate using a 100 lL syringe. The chromatographic con-
ditions were adopted for each laboratory- prepared mixture
and the concentrations for each drug were calculated from
the regression equations. Each concentration was conducted
from the average of three experiments.
2.4.2.5. Application to pharmaceutical preparation. Five millili-
ters of Fluca eye drops was transferred into 25 mL volumetric
ﬂask, the volume was completed with solvent mixture to get
4000 lg/mL of SCG and 200 lg/mL of FLU. The prepared
solution was ﬁltered through 0.45 lm Millipore syringe mem-
brane ﬁlter and an appropriate dilution was made from the
same solvent to prepare a solution of 400 lg/mL SCG and
20 lg/mL FLU. Ten microliters of the solution was applied
to a TLC plate using a 100 lL syringe. The chromatographic
conditions were applied and the chromatograms were re-
corded. Six replicates were done .The concentrations of SCG
and FLU were calculated from their corresponding regression
equations. The standard addition technique was applied by
adding different known concentrations of pure standard drugs
to the pharmaceutical formulation before proceeding in the
previously mentioned method.3. Results and discussion
The aim of this work was to develop simple, sensitive, selective
and precise spectrophotometric and TLC-spectrodensitometric
methods for simultaneous estimation of SCG and FLU in their
pure form and ophthalmic solution.
3.1. For spectrophotometric methods
Two major problems raised upon the analysis of this binary
mixture which were: the overlapped spectra with a large differ-
ence between the absorptivities of the two drugs; and the ratio
of the drugs in the dosage form SCG:FLU (20:1) which make
it difﬁcult to determine FLU accurately. On the analysis of
mixtures of compounds of largely variable absorptivities, there
is a need to use higher concentrations of the component mix-
ture solution to analyze those with low absorptivity which
may lead to a deviation from Beer’s law due to the electrostatic
attraction between ions (Harvey, 2000). To facilitate the deter-
mination of the minor component (FLU), there is a need to in-
crease its concentration in the binary mixture using sample
enrichment technique. This is done adding ﬁxed amounts of
standard FLU to each experiment then subtract its concentra-
tion before calculating the claimed concentration of the drug.
This technique has been used to solve the same problem for
analyzing other drug mixtures (Lotfy, 2006; Lotfy and Hagazy,
2012). The UV absorption spectra (D0) of SCG and FLU are
shown in Fig. 2, where FLU could not be resolved by direct
derivative spectrophotometry. So, different spectral manipu-
lating techniques have been applied. All spectral measurements
were done without interference of benzalkonium chloride
which did not show any absorption and its contribution to
the absorption of the mixture above 220 nm was considered
to be negligible at a concentration up to100 lg/mL, so the ter-
nary mixture in the range (220–400 nm) acts as a binary mix-
ture of FLU and SCG.
Figure 2 (a) UV spectra of 5 lg/mL of SCG, 10 lg/mL of FLU and 10 lg/mL of benzalkonium chloride, (b) 1st derivative spectra D1 of
5 lg/mL of SCG and 10 lg/mL of FLU.
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This method is considered as a modiﬁcation of isoabsorptive
technique, but in the isoabsorptive technique the spectra of
the same concentrations of the two studied drugs should cross
at a point called isoabsorptive point at which they have equal
absorptivities, while in absorptivity factor method the crossing
point did not occur at equal concentration so the crossing
point is obtained between different concentrations of the two
drugs. At this point the absorptivities of the two drugs are
not equal but they are equal to the inverse of the ratio of the
used concentrations.
The UV absorption spectra (D0) of SCG and FLU are
shown in Fig. 2, showing two crossing absorptivity factor
points (kF) at 227.8 and 282 nm. Both points were tested
for the determination of mixture, but the later one
(282 nm) showed a bad linearity correlation (0.9955) for both
drugs due to their low absorptivities at this wavelength,
subsequently bad recoveries were obtained for the mixtures.
So the ﬁrst point 227.8 nm (linearity correlation = 0.9999)Figure 3 Ratio spectra of SCG (5 lg/mL), FLU (10 lg/mL) and mixt
FLU as a divisor, (b) using 10 lg/mL of SCG as a divisor.was chosen to calculate the absorptivity factor where the
absorptivity of SCG is double that of FLU (aSCG/
aFLU = F= 2). The concentration of the mixture that repre-
sents (CFLU + 2CSCG) can be calculated by using a regression
equation representing the linear relationship between the
absorbance of FLU and its corresponding concentration at
the absorptivity factor points kF (227.8 nm). Thus, the con-
centration of SCG (CSCG) in the mixtures can be determined
separately by using its D0 at 325 nm in a concentration range
of (7.5–40 lg/mL); or by using the ﬁrst derivative spectra
D1of SCG to solve its overlapping with FLU, Fig. 2, mea-
sured at 241.5 nm in a concentration range with higher sensi-
tivity (2.5–35 lg/mL) due to its higher absorptivity at this
wavelength. Then the concentration of FLU (CFLU) can be
calculated as follows:
Amix ¼ aFLUðCFLU þ 2CSCGÞatkF
CFLU ¼ ðCFLU þ 2CSCGÞ  ð2XCSCGÞ:ure of 5 lg/mL of SCG and 10 lg/mL of FLU (a) using 8 lg/mL of
Figure 4 Mean centered ratio spectra of (a) SCG (2.5–35 lg/mL) using 8 lg/mL FLU as a divisor and (b) FLU (2–16 lg/mL) using
10 lg/mL SCG as a divisor.
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kF (227.8 nm), CFLU and CSCG are the concentrations of FLU
and SCG, respectively.
3.1.2. AFM
This method (Patel et al., 2007; Prajapati et al., 2011) describes
the analysis of a binary mixture where the two components X
and Y have overlapped spectra. Y shows interference at max of
X (1), while X shows no interference with Y at another wave-
length (2). As shown in Fig. 2, the absorption spectra of SCG
and FLU show severe overlap in the wavelength region of 200–
300 nm. So, the absorption spectra of the standard solutions of
the SCG with different concentrations were recorded in the
wavelength range of 200–400 nm, and the average value of
absorption factor (abs 241 nm/abs 325 nm) was found to be
3.355. Since the absorbance of the mixture (SCG+ FLU) atFigure 5 2D TLC chromatogram of (a) 4 lg/band of SCG and (b) 0
in ratio of (5:2:4:1 v/v/v/v) as developing system.325 nm is equal to that of pure SCG due to lack of contribu-
tion of FLU at this wavelength, the absorption of FLU could
be calculated using the following equation:
Absorption of FLU at241nm ¼ abs241ðSCGþ FLUÞ  abc1
abs2
 abs325ðSCGþ FLUÞ
where; abc1
abs2
is the absorption factor of pure SCG (abs 241 nm/
abs 325 nm = 3.355), abs 241 (SCG+ FLU) is the absorbance
of the mixture at 241 nm, but abs 325 (SCG+ FLU) = abs 325
SCG only at 325 nm.
The concentrations of SCG and FLU were calculated from
the corresponding regression equation obtained by plotting the
absorption values of the zero order spectra, at 325 and 241 nm,
against the corresponding concentrations, respectively..2 lg/band FLU using chloroform:methanol:toluene:triethylamine
Table 1 Statistical analysis of parameters required for system suitability of TLC-spectrodensitometric method.
Parameter OFX DXM Reference value Afkhami and Bahram (2004)
Rf value 0.1 ± 0.01 0.58 ± 0.02
T (tailing factor) 0.83 1.01 T< 2
T= 1 for symmetric peak
Rs (experimental resolution) 10 Rs > 2
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This is a well-established spectrophotometric method (Afkh-
ami and Bahram, 2004; Zarei et al., 2009; Darwish et al.,
2011) where the constant obtained in the ratio spectra of a
mixture is removed by mean centering (MC). A linear relation
is obtained for the (MC) amplitude of one component against
its concentration. This method eliminates derivative steps and
therefore signal-to-noise ratio is enhanced.
The ratio spectra for both drugs were obtained by testing
different concentrations of the divisors (5, 10 and 15 lg/mL
of SCG) and (4, 8 and 12 lg/mL of FLU) but the concentra-
tions 10 lg/mL of SCG and 8 lg/mL of FLU gave minimum
noise in ratio spectra and maximum sensitivity as shown in
Fig. 3. The ratio spectra were mean centered in the range
(200–300 nm) for SCG and (200–350 nm) for FLU, Fig. 4;
the remaining spectra were eliminated as it affected the linear-
ity of the MC curves. The concentration of both drugs was cal-
culated by using the regression equation representing the linear
relationship between (MC) at 252.2 nm for SCG and FLU.
3.2. For TLC-spectrodensitometric method
This method offers a simple way for quantiﬁcation directly on
TLC plate by measuring the optical density of the separated
bands. The amounts of compounds are determined by compar-
ing to a standard curve from reference materials chromato-
graphed simultaneously under the same condition (Wagieh
et al., 2010; Kasaye et al., 2010).Table 2 Assay parameters and method validation obtained by app
Parameters a-Factor method AFM
SCG FLU SCG FL
Wavelength (in nm) D1 at 241.5 D0 at 227.8 D0 at 325 D0
Calibration rangea 2.5–35 4–16 7.5–50 4–
LOD 0.426 0.105 0.189 0.0
LOQ 1.290 0.317 0.574 0.2
Slope 0.0279 0.0283 0.0167 0.0
Intercept 0.0067 0.0033 0.0011 0.0
Mean %b 100.31 100.11 100.23 99
RSD % 0.90 0.56 0.57 0.3
Accuracyb 100.73/0.97 101.2/0.80 100.11/0.20 10
Intra-day precisionc 100.57/0.61 100.2/0.39 99.90/0.50 10
Inter-day precisionc 100.21/0.46 100.2/0.46 100.37/0.40 10
Robustness 99.47/0.93 99.75/1.41 99.58/1.13 10
Correlation coeﬃcient (r) 0.9999 0.9999 0.9999 0.9
LOD, limit of detection, LOQ, limit of quantitation; in lg/mL for spectr
D0, zero order spectra; D
1, 1st derivative spectra; MC, mean centered sp
a Calibration points: n= 8 for spectrophotometric methods, n= 7 f
methods, lg/band for TLC method.
b Average of three experiments.
c Mean percentage recoveries/RSD of three samples of SCG and FLUTo optimize the method conditions, it was necessary to test
the effect of different variables. In order to separate the two
drugs from each other, several ratios of different developing
systems were checked. Increasing the ratio of chloroform
slightly affected the separation of SCG but it affected the
migration of FLU to the solvent front. Methanol caused an in-
crease in Rf of both drugs but SCG bands showed tailing and
FLU bands migrated to the solvent front. Toluene affected the
migration of FLU only to higher Rf but caused tailed peaks,
while triethylamine was necessary to reduce the tailing of both
peaks. Finally it was found that the best separation of SCG
and FLU was obtained by applying the developing system
using chloroform:methanol:toluene:triethylamine (5:2:4:1 v/v/
v/v). Due to the great difference in polarities between the
two drugs; SCG was separated at Rf = 0.1 ± 0.01 while
FLU was separated at Rf = 0.58 ± 0.02. Different scanning
wavelengths were tried (241, 236.3 and 325 nm); on using
241 nm, the separated peaks were more sharp and symmetrical
with minimum noise, as shown in Fig. 5.
The parameters of system suitability of the TLC-spectro-
densitometric are listed in Table 1. The corresponding concen-
tration ranges, calibration equations and other statistical
parameters for the proposed methods were listed in Table 2.
The selectivity of the proposed procedures was assessed by
the analysis of laboratory prepared mixtures containing differ-
ent ratios of the two drugs, where satisfactory results were ob-
tained over the calibration ranges as shown in Table 3. The
proposed procedures were also applied for the determinationlying the proposed methods.
MCR TLC- method
U SCG FLU SCG FLU
at 241 MC at 252.2 MC at 252.2 241 241
16 2.5–35 2–16 0.4–4.4 0.2–1.6
89 0.343 0.163 0.107 0.034
69 1.038 0.494 0.323 0.103
397 0.2733 0.0601 0.8206 1.7669
001 0.1207 0.0002 1.562 0.6891
.97 100.43 99.94 100.24 99.95
5 1.21 0.88 1.44 1.50
0.9/0.92 100.63/0.91 100.24/1.23 99.02/0.72 100.60/0.75
0.1/0.45 100.37/0.71 99.81/0.63 100.08/0.70 100.25/0.65
0.02/0.55 100.11/0.79 100.10/0.59 100.04/0.64 100.12/0.23
0.38/1.09 99.54/0.68 99.65/0.53 100.64/0.63 99.63/1.45
999 0.9998 0.9999 0.9997 0.9997
ophotometric methods; in lg/band for TLC method.
ectra.
or TLC method, Concentration in lg/mL for spectrophotometric
.
Table 3 Determination of SCG and FLU in laboratory prepared mixtures by applying the proposed methods.
SCG:FLU in (lg/mL)a in (lg/band)b a-Factor method AFM MCR TLC
SCGc FLUa SCG FLUa SCG FLUa SCGb FLUb
Recovery % d
10:10 100.12 99.62 99.34 98.64 100.83 100.00 98.33 101.67
10:5 99.74 98.40 99.94 100.27 98.38 102.23 99.38 101.25
20:4 102.93 101.00 101.47 99.87 99.22 99.67 99.75 100.00
20:2 101.68 99.76 100.87 100.72 101.07 98.96 99.50 102.50
20:1e 100.96 101.59 100.57 98.37 99.86 100.01 100.25 100.00
Mean 101.08 100.07 100.44 99.58 99.87 100.18 99.44 101.08
±SD ±1.28 ±1.25 ±0.82 ±1.02 ±1.12 ±1.23 ±0.70 ±1.09
a Concentration of SCG and FLU is calculated in (lg/mL) after subtraction of spiked FLU concentration (4 lg/mL).
b Concentration of SCG and FLU is calculated in (lg/band).
c Using D1 method at 241.5 nm.
d Average of three experiments.
e Ratio present in Fluca eye drops.
418 S.S. Saleh et al.of SCG and FLU in Fluca eye drops; and were compared to
the manufacturer HPLC method (Organization for Drug
Control and - Quality Control Department, XXXX). The
validity of the proposed procedures is further assessed by
applying the standard addition technique showing no excipi-
ents interference. The results obtained were shown in Table 4.
4. Methods validation
Method validation was performed according to ICH guidelines
(ICH, 2005) as follows:
4.1. Range and linearity
The linearity of the proposed methods was evaluated by pro-
cessing the different calibration curves on three different days.
The calibration curves were constructed within concentration
ranges that were selected on the basis of the anticipated drugs
concentration during the assay of the dosage form. The rangesTable 4 Application of standard addition technique to the analysi
applying the proposed methods.
Methods SCG
Founda in
lg/mL b lg/band c
Found recovery
%± S.D
Pure adde
recovery %
a-Factor methodb,e 101.59 ± 0.48 100.24 ± 0.21 0.994
AFMb 20.318 101.59 ± 0.39 100.39 ± 0
MCRb 20.301 101.50 ± 0.99 100.02 ± 0
TLCc 4.039 100.97 ± 0.27 100.60 ± 0
Manufacturer HPLC
method Zarei et al.
(2009)b f
20.25 101.26 ± 0.52
a Average of six experiments.
b SCG claimed to be 20 lg/mL and FLU to be 1 lg/mL (after subtract
c SCG claimed to be 4 lg/band and FLU to be 0.2 lg/band.
d Average of three experiments (SCG and FLU added equivalent to 2,
e Using D1 method at 241.5 nm.
f Manufacturer HPLC method using RP C18 and mobile phase: 4.243 g
1 L of water, pH 2.1 adjusted with o-H3PO4, ﬂow rate 1 ml/min, detectiofor FLU were (2–16 lg/mL) using MCR, while for the a-factor
method and AFM the ranges were found to be (4–16 lg/mL).
This is contributed to the enhancement of the signal to noise
ratio upon using MCR. Using AFM, SCG should be measured
at its D0 at 325 nm in a concentration range of (7.5–40 lg/mL),
unlike the a-Factor method where we could utilize the D1of
SCG at 241.5 nm in a concentration range of (2.5–35 lg/mL)
to increase the sensitivity of SCG determination. The corre-
sponding concentration ranges, calibration equations and
other statistical parameters for the proposed methods are listed
in Table 2.4.2. Limits of detection and quantiﬁcation
The limit of detection (LOD) and limit of quantiﬁcation
(LOQ) were calculated respectively, for both drugs using the
proposed methods with a ratio of 3.3 and 10 standard devia-
tions of the blank and the slope of the calibration line, Table 2.s of SCG and FLU in Fluca eye drops (batch no. LM036) by
FLU
dd
± S.D
Founda in
lg/mL b lg/band c
Found recovery
%± S.D
Pure addedd
recovery %± S.D
99.44 ± 0.81 99.93 ± 0.24
.26 0.998 99.84 ± 0.52 100.14 ± 0.12
.07 0.994 99.38 ± 0.60 100.08 ± 0.46
.35 0.199 99.76 ± 0.44 100.26 ± 0.54
0.993 99.31 ± 0.74
ion of spiked FLU concentration 4 lg/mL).
4, 6 lg/mL, for TLC:0.4, 0.5, 0.6 lg/band).
of tetrabutyl ammonium hydrogen sulfate + 5 ml of triethylamine in
n at 254 nm.
Table 5 Statistical comparison between the results obtained by the proposed method and the ofﬁcial BP methods British
Pharmacopoeia (2009) for the determination of SCG and FLU in pure powder form.
Items SCG FLU
a-Factor
method b
AFM MCR TLC Oﬃcial method a
British Pharmacopoeia
(2009)
a-Factor
method
AFM MCR TLC Oﬃcial method a British
Pharmacopoeia (2009)
Mean % 100.28 100.23 100.43 100.24 100.80 100.11 99.97 99.94 100.23 100.12
RSD 0.78 0.57 1.21 1.74 0.74 0.56 0.35 0.88 0.57 0.52
SEM 0.28 0.20 0.46 0.66 0.33 0.20 0.13 0.31 0.36 0.23
n 8 8 8 7 5 8 8 8 7 5
Student’s t-test
(2.201)c (2.228)d
1.203 1.570 0.612 0.670 0.032 0.617 0.393 0.245
F value (6.094)c
(6.163)d
1.108 1.719 2.669 5.508 1.176 2.137 2.923 3.392
SEM, standard error of mean.
a BP method for SCG is potentiometric titration method, while for FLU is HPLC method.
b Using D1 method at 241.5 nm.
c Figures between parentheses represent the corresponding tabulated values of t and F at P= 0.05 at 11 degree of freedom.
d Figures between parentheses represent the corresponding tabulated values of t and F at P= 0.05 at 10 degree of freedom.
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To study the accuracy of the proposed methods, procedures
under study of linearity, for both drugs using the proposed
methods, were repeated three times for the determination of
different concentrations of SCG and FLU within the linearity
range. The accuracy expressed as mean percentage recoveries
and relative standard deviation (RSD) was shown in Table 2.
The interference of excipients in the pharmaceutical formula-
tions was studied by applying standard addition method to
the pharmaceutical formulation. Good accuracy proved that
the excipients in pharmaceutical formulation did not interfere
in the analysis of these compounds in the pharmaceutical for-
mulation as shown in Table 4.
4.4. Precision
The inter-day and intra-day precisions of the proposed meth-
ods were determined by the analysis of three different concen-
trations of SCG and FLU, within the linearity range, by three
replicate analyses of three pure samples of both drugs on a sin-
gle day and on three consecutive days, respectively. The results
expressed as mean percentage recoveries and RSD are illus-
trated in Table 2.Table 6 Results of ANOVA (single factor) for comparison of the
pharmaceutical dosage form.
Source of variation Degree of freedom
SCG Between columns 3
Within columns 20
Total 23
FLU Between columns 3
Within columns 20
Total 23
a There was no signiﬁcant difference between the methods using one-w4.5. Selectivity
Selectivity was ascertained by analyzing different mixtures
containing both drugs in different ratios within the linearity
range. Satisfactory results were shown in Table 3.4.6. Robustness
For the spectrophotometric methods, testing for robustness in-
volved performing the spectral measurements at ±1 nm for
three different concentrations of SCG and FLU. The robust-
ness was calculated as mean percentage recoveries and relative
standard deviation as shown in Table 2, where the a-Factor
method showed the highest value of RSD. This could be justi-
ﬁed by the critical measurement of absorbance at absorptivity
factor point (kF) at 227.8 nm as any minor change in the se-
lected wavelength will affect the results and subsequently
shows poor robustness. For the TLC-spectrodensitometric
methods, the analysis of samples was done under a variety of
experimental conditions, such as small changes in proportions
of different components by up to ±0.5%mainly of the organic
parts of the developing systems. The effect on Rf values and
peak parameters was studied. The methods proved to beproposed methods for the determination of SCG and FLU in
Sum of squares Mean square F value a P value a
1.592 0.5306 1.455 0.2568
7.294 0.3647
8.885
0.9224 0.3075 0.8281 0.4939
7.427 0.3713
8.349
ay ANOVA at P< 0.05.
420 S.S. Saleh et al.robust and the percentage recoveries and RSD were calculated,
Table 2.
5. Statistical analysis
Table 5 showed statistical comparison of the results obtained
by the proposed methods and ofﬁcial methods (British
Pharmacopoeia, 2009). The calculated t and F values were less
than the theoretical ones indicating that there was no signiﬁ-
cant difference between the proposed and the ofﬁcial methods
with respect to accuracy and precision. One-way ANOVA was
applied for the purpose of comparison of developed methods;
Table 6 shows that there was no signiﬁcant difference between
them.
6. Conclusion
Themain advantage of the absorptivity factormethod (a-Factor
method) and absorption factor method (AFM) over the mean
centering of ratio spectra method (MCR) is the application of
simple mathematic equation to calculate the concentration of
both components in binary mixture with different absorptivi-
ties either at the same wavelength (absorptivity factor method)
or at different wavelength (absorption factor method) using
their zero order spectra with no need for advanced expensive
software or device (as Matlab in MCR). The advantage of a-
Factor method over the AFM is that the application of the last
one is limited for the determination of binary mixture where
one of the two component shows two maxima in the zero order
absorption spectrum at two different wavelengths and the
other component should not interfere at one of them; while
the a-factor method has no limitation as it can utilize any spec-
trophotometric method to calculate the concentration of one
component then calculate the others by a simple mathematical
calculation. The MCR has the advantage of being more sensi-
tive by enhancing the signal to noise ratio due to lack of deriv-
atization. The TLC-spectrodensitometric method has the
advantage of minimizing the cost of reagents and time for
analysis. It also utilizes the merit of applying several sample
bands on TLC plate, which may be more advantageous for
regulatory quality control laboratories. In addition, the meth-
od is inexpensive and not requires certain types of stationary
phases. As a ﬁnal conclusion, the proposed methods proved
to be accurate, precise and sensitive, and they have the advan-
tage of being simpler as they do not require any sophisticated
apparatus, as manufacturer HPLC method. The proposed
methods could be easily applied in quality control laboratories
as they show similar accuracy and precision compared to the
manufacturer HPLC method for the simultaneous determina-
tion of sodium cromoglicate and ﬂuorometholone, in addition
to their lower cost.
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